X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1150) 1150
Publication (86) 86
Book Chapter (24) 24
Book Review (22) 22
Conference Proceeding (2) 2
Magazine Article (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (848) 848
index medicus (504) 504
female (457) 457
male (436) 436
liver transplantation (398) 398
transplantation (396) 396
middle aged (371) 371
adult (355) 355
recurrence (337) 337
gastroenterology & hepatology (334) 334
surgery (304) 304
hepatitis c (221) 221
liver (208) 208
aged (203) 203
treatment outcome (188) 188
recurrent (177) 177
recipients (172) 172
immunology (158) 158
infection (156) 156
risk factors (143) 143
recurrent hepatitis-c (135) 135
retrospective studies (135) 135
antiviral agents - therapeutic use (132) 132
cirrhosis (130) 130
health aspects (121) 121
hepatitis c virus (118) 118
immunosuppression (115) 115
liver transplantation - adverse effects (114) 114
ribavirin (114) 114
disease (112) 112
interferon (111) 111
recurrent infection (109) 109
survival (108) 108
biopsy (104) 104
hepatitis (101) 101
therapy (100) 100
hepatitis c - surgery (95) 95
rejection (94) 94
time factors (94) 94
analysis (91) 91
immunosuppressive agents - therapeutic use (87) 87
virus-infection (86) 86
follow-up studies (85) 85
prognosis (83) 83
antiviral therapy (81) 81
liver - pathology (79) 79
hepacivirus - genetics (76) 76
care and treatment (74) 74
hepatitis c - complications (72) 72
adolescent (71) 71
recurrent hepatitis (70) 70
drug therapy, combination (69) 69
recurrent hepatitis c (68) 68
hepatitis c - drug therapy (67) 67
fibrosis (66) 66
medicine & public health (66) 66
fibrosis progression (64) 64
patients (64) 64
tacrolimus (64) 64
cancer (62) 62
graft survival (62) 62
infections (61) 61
oncology (61) 61
allografts (60) 60
animals (60) 60
liver cirrhosis (60) 60
natural-history (58) 58
diseases (56) 56
hepatocellular carcinoma (56) 56
pregnancy (56) 56
graft rejection (55) 55
liver diseases (55) 55
transplants & implants (55) 55
virus (55) 55
genotype (54) 54
liver cirrhosis - virology (54) 54
ribavirin - therapeutic use (53) 53
diagnosis (52) 52
disease progression (52) 52
hepatitis c, chronic - drug therapy (52) 52
hepatocellular-carcinoma (51) 51
management (51) 51
liver transplantation - immunology (50) 50
relapse (49) 49
risk (49) 49
survival rate (49) 49
recurrent disease (48) 48
risk-factors (48) 48
rna (48) 48
development and progression (47) 47
immunotherapy (47) 47
infectious diseases (47) 47
liver transplantation - mortality (47) 47
medicine, general & internal (47) 47
child (46) 46
gastroenterology and hepatology (46) 46
research (46) 46
liver cirrhosis - surgery (45) 45
medical research (45) 45
recombinant proteins (45) 45
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1072) 1072
French (83) 83
Spanish (8) 8
German (4) 4
Korean (4) 4
Italian (1) 1
Japanese (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Gastroenterology, ISSN 0944-1174, 05/2018, Volume 53, Issue 5, pp. 591 - 605
Hepatitis C virus (HCV) infection is one of the primary causes of liver cirrhosis and hepatocellular carcinoma. In hemodialysis patients, the rate of HCV... 
HCV | HIV | Hemodialysis | Direct-acting antiviral | Liver transplantation | LIVER-TRANSPLANT RECIPIENTS | HUMAN-IMMUNODEFICIENCY-VIRUS | SUSTAINED VIROLOGICAL RESPONSE | SOFOSBUVIR PLUS RIBAVIRIN | ANTIVIRAL TRIPLE THERAPY | HEMODIALYSIS-PATIENTS | GENOTYPE 1 INFECTION | CHRONIC KIDNEY-DISEASE | GASTROENTEROLOGY & HEPATOLOGY | ASUNAPREVIR COMBINATION THERAPY | SEVERE RENAL IMPAIRMENT | Recurrence | Liver Transplantation | Antiviral Agents - pharmacokinetics | Hepatitis C - drug therapy | Antiviral Agents - therapeutic use | Coinfection - drug therapy | Humans | Ribavirin - therapeutic use | Postoperative Period | Interferons - therapeutic use | Antiviral Agents - metabolism | Renal Insufficiency, Chronic - complications | Renal Insufficiency, Chronic - physiopathology | Renal Insufficiency, Chronic - therapy | Antiviral Agents - adverse effects | HIV Infections - complications | HIV Infections - drug therapy | Hepatitis C - complications | Immunocompromised Host | Drug Therapy, Combination | Protease Inhibitors - therapeutic use | Renal Dialysis | Medical colleges | Liver | Transplantation of organs, tissues, etc | Interferon | Biological response modifiers | Hepatitis C virus | Hepatitis C | Drug therapy | HIV (Viruses) | Health aspects | Liver cirrhosis | Recurrent infection | Syngeneic grafts | Hepatocellular carcinoma | Infections | Transplantation | Cirrhosis | Hepatitis | Allografts | Human immunodeficiency virus--HIV | Fibrosis | Review
Journal Article
Journal Article
Liver Transplantation, ISSN 1527-6465, 10/2002, Volume 8, Issue 10, pp. S14 - S18
Journal Article
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 2017, Volume 64, Issue 1, pp. 44 - 52
Journal Article
Journal Article
Journal Article
13.